Bionano Genomics Inc

NASDAQ:BNGO  
0.49
0.00 (0.00%)
Earnings Announcements

Bionano Genomics Reports Q3 Rev Of $2.2 Mln

Published: 11/12/2020 21:12 GMT
BioNano Genomics Inc (BNGO) - Bionano Genomics Reports Third Quarter 2020 Financial Results and Provides Business Update.
Q3 Revenue $2.2 Million Versus Refinitiv Ibes Estimate of $2.1 Million.
Revenue is expected to be $3.03 Million
Adjusted EPS is expected to be -$0.06

Next Quarter Revenue Guidance is expected to be $3.6 Million
Next Quarter EPS Guidance is expected to be -$0.05

More details on our Analysts Page.